| Company Name: |
Zhengzhou Granlen Sciences, ltd.
|
| Tel: |
0371-85513397 +86-18610099868 |
| Email: |
info@granlen.com |
| Products Intro: |
Product Name:N6-iso-Propyl-2’-O-methyladenosine
Purity: 95% HPLC Package:根据客户需要包装 Remarks:GL105082
|
| Company Name: |
Shanghai meikai technology co., ltd
|
| Tel: |
021-68689288 15300790979 |
| Email: |
info@mkbio.com.cn |
| Products Intro: |
Product Name:(2R,3R,4R,5R)-2-(hydroxymethyl)-5-(6-(isopropylamino)-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-ol
CAS:2803878-84-2
Purity:98% Package:100mg;250mg;1g
|
N6-iso-Propyl-2’-O-methyladenosine manufacturers
|
| | N6-iso-Propyl-2’-O-methyladenosine Basic information |
| | N6-iso-Propyl-2’-O-methyladenosine Chemical Properties |
| Boiling point | 600.258±65.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.562±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 13.133±0.70(predicted) |
| | N6-iso-Propyl-2’-O-methyladenosine Usage And Synthesis |
| Uses | N6-iso-Propyl-2’-O-methyladenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500. DOI:10.1016/j.drudis.2021.02.020
[2] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | N6-iso-Propyl-2’-O-methyladenosine Preparation Products And Raw materials |
|